| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8764348 | Medicine - Programa de Formación Médica Continuada Acreditado | 2018 | 8 Pages |
Abstract
Oral steroids are the basic pillar of treatment. They are often associated with corticosteroid-sparing immunosuppressive agents. Rituximab is increasingly used as second line treatment; it induces B-lymphocyte depletion and lasting remission.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
A. Fueyo Casado, M.L. González, E. López Bran,